FDA approves 3+ new blockbuster drugs by Dec 2026

The FDA’s leadership instability will delay non-urgent approvals, but political pressure to accelerate drug approvals will force at least three major drug approvals by year-end. The agency will prioritize high-profile treatments to stabilize its reputation.

Implied probability (Yes)

60%